# active_site_0030

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **A** — Position 141 (Proton acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAEFVRAQIFGTTFEITSRYTELAPVGMGAFGLVCSAKDQLTNQAVAVKKIMKPFSTPVLSKRTYRELKLLKHLRHENVISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILVNENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSVGCIFAEMLEGKPLFPGKDHVNQFSIITELLGTPPDDVIQTICSENTLRFVQSLPKRERQPLTKKFKNADPQAIELLERMLVFDPRTRIRAGDALADPYLAPYHDPTDEPEAEEKFDWSFNDADLPVDTWKIMMYSEILDYHNVDAQNGEEVGVPQ

[Multiple Choices]
A. Position 141 (Proton acceptor)
B. Position 2711 (For beta-ketoacyl synthase 2 activity)
C. Position 2153 (For beta-ketoacyl synthase 2 activity)
D. Position 279 (Proton donor/acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied 355-residue sequence matches the UniProt HOG1 sequence. UniProt annotates position 141 as an active-site proton acceptor, with support from a PROSITE-ProRule computational annotation; the matched historical record contains the same annotation. Position 141 is the Asp in the conserved kinase HRD motif. This supports the key, though it is not direct experimental validation.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the conserved kinase HRD motif at positions 139–141; its Asp at position 141 is a characteristic catalytic residue and matches option A. The sequence is only 355 residues long, ruling out the positions in B and C; position 279 is not the HRD catalytic Asp.


**Missing item-specific fact**

> No protein-specific annotation is necessary to distinguish A by the conserved kinase motif, although an annotation or experiment would be needed to establish the residue's precise proton-transfer role with greater certainty.


**Reason**

> The supplied sequence and choices provide a concrete, biologically meaningful basis for selecting A, rather than requiring recognition of a database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The kinase HRD-motif Asp at position 141 clearly distinguishes A from the other listed positions.


### Important caveats

- The cited UniProt active-site annotation is computationally inferred from PROSITE-ProRule, not identified here as experimental evidence.
- The reviewer-only evidence confirms sequence identity and annotation but was not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the conserved kinase HRD motif at positions 139–141; its Asp at position 141 is a characteristic catalytic residue and matches option A. The sequence is only 355 residues long, ruling out the positions in B and C; position 279 is not the HRD catalytic Asp.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "No protein-specific annotation is necessary to distinguish A by the conserved kinase motif, although an annotation or experiment would be needed to establish the residue's precise proton-transfer role with greater certainty.",
    "reason": "The supplied sequence and choices provide a concrete, biologically meaningful basis for selecting A, rather than requiring recognition of a database entry."
  },
  "case_id": "active_site_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied 355-residue sequence matches the UniProt HOG1 sequence. UniProt annotates position 141 as an active-site proton acceptor, with support from a PROSITE-ProRule computational annotation; the matched historical record contains the same annotation. Position 141 is the Asp in the conserved kinase HRD motif. This supports the key, though it is not direct experimental validation."
  },
  "important_caveats": [
    "The cited UniProt active-site annotation is computationally inferred from PROSITE-ProRule, not identified here as experimental evidence.",
    "The reviewer-only evidence confirms sequence identity and annotation but was not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The kinase HRD-motif Asp at position 141 clearly distinguishes A from the other listed positions."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied 355-residue sequence matches the UniProt HOG1 sequence. UniProt annotates position 141 as an active-site proton acceptor, with support from a PROSITE-ProRule computational annotation; the matched historical record contains the same annotation. Position 141 is the Asp in the conserved kinase HRD motif. This supports the key, though it is not direct experimental validation.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the conserved kinase HRD motif at positions 139–141; its Asp at position 141 is a characteristic catalytic residue and matches option A. The sequence is only 355 residues long, ruling out the positions in B and C; position 279 is not the HRD catalytic Asp.",
    "missing_item_specific_fact": "No protein-specific annotation is necessary to distinguish A by the conserved kinase motif, although an annotation or experiment would be needed to establish the residue's precise proton-transfer role with greater certainty.",
    "reason": "The supplied sequence and choices provide a concrete, biologically meaningful basis for selecting A, rather than requiring recognition of a database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The kinase HRD-motif Asp at position 141 clearly distinguishes A from the other listed positions."
  },
  "important_caveats": [
    "The cited UniProt active-site annotation is computationally inferred from PROSITE-ProRule, not identified here as experimental evidence.",
    "The reviewer-only evidence confirms sequence identity and annotation but was not available to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (C5/H3) explicitly lists ACT_SITE at position 141, 'Proton acceptor', with evidence ECO:0000255|PROSITE-ProRule:PRU00159. Position 141 in the 355-aa sequence corresponds to the aspartate in the HRD catalytic motif (H139-R140-D141), which is the canonical proton-accepting residue in protein kinases. The annotation is computational (PROSITE-ProRule pattern transfer from the kinase family, ECO:0000255), not experimentally validated, but it is the authoritative database assignment for this entry.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Three independent reasoning steps distinguish the answer: (1) The protein is 355 amino acids long, so options B (position 2711) and C (position 2153) are physically impossible and are eliminated by simple arithmetic. (2) The sequence contains the hallmark motifs of a eukaryotic protein kinase: a VAIK-type lysine (K49), the HRD catalytic triad (H139-R140-D141), the DFG motif (D159-F160-G161), and the activation-segment APE motif (~position 195). Recognizing these is general kinase biochemistry. (3) In protein kinases the HRD aspartate is the catalytic proton acceptor; it sits at position 141 in this sequence. Position 279 falls in the C-terminal regulatory tail ('FNDADLPVDTWKIMMYSEILDYHNVDAQNGEEVGVPQ'), far from the catalytic cleft, making it implausible as the catalytic center. Thus only option A survives.


**Missing item-specific fact**

> None required. The kinase-motif architecture is visible in the supplied sequence, and the two impossible positions are eliminated by length alone.


**Reason**

> A knowledgeable reader can (a) reject B and C because their positions exceed the 355-residue sequence, (b) identify the protein as a kinase from conserved motifs embedded in the sequence, and (c) locate the HRD aspartate (proton acceptor) at position 141 versus a non-catalytic residue at position 279 in the C-terminal tail. No item-specific database lookup is needed.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options B and C are eliminated outright by sequence length. Option D (position 279) is in the C-terminal tail, inconsistent with a kinase active site. Only option A is biologically defensible.


### Important caveats

- The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational pattern-transfer annotation from the protein-kinase family, not a direct experimental measurement.
- The UniProt entry (A0A5B9GBF0, HOG1_AURME) was first released 2025-02-05; the benchmark author's exact source snapshot is unknown, though the sequence has not changed (sequenceVersion 1 throughout).
- The reviewer identified the accession via dataset image-path metadata, which was not available to the evaluated model; however, the reasoning argument relies only on the supplied sequence and general kinase biology.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Three independent reasoning steps distinguish the answer: (1) The protein is 355 amino acids long, so options B (position 2711) and C (position 2153) are physically impossible and are eliminated by simple arithmetic. (2) The sequence contains the hallmark motifs of a eukaryotic protein kinase: a VAIK-type lysine (K49), the HRD catalytic triad (H139-R140-D141), the DFG motif (D159-F160-G161), and the activation-segment APE motif (~position 195). Recognizing these is general kinase biochemistry. (3) In protein kinases the HRD aspartate is the catalytic proton acceptor; it sits at position 141 in this sequence. Position 279 falls in the C-terminal regulatory tail ('FNDADLPVDTWKIMMYSEILDYHNVDAQNGEEVGVPQ'), far from the catalytic cleft, making it implausible as the catalytic center. Thus only option A survives.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None required. The kinase-motif architecture is visible in the supplied sequence, and the two impossible positions are eliminated by length alone.",
    "reason": "A knowledgeable reader can (a) reject B and C because their positions exceed the 355-residue sequence, (b) identify the protein as a kinase from conserved motifs embedded in the sequence, and (c) locate the HRD aspartate (proton acceptor) at position 141 versus a non-catalytic residue at position 279 in the C-terminal tail. No item-specific database lookup is needed."
  },
  "case_id": "active_site_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (C5/H3) explicitly lists ACT_SITE at position 141, 'Proton acceptor', with evidence ECO:0000255|PROSITE-ProRule:PRU00159. Position 141 in the 355-aa sequence corresponds to the aspartate in the HRD catalytic motif (H139-R140-D141), which is the canonical proton-accepting residue in protein kinases. The annotation is computational (PROSITE-ProRule pattern transfer from the kinase family, ECO:0000255), not experimentally validated, but it is the authoritative database assignment for this entry."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational pattern-transfer annotation from the protein-kinase family, not a direct experimental measurement.",
    "The UniProt entry (A0A5B9GBF0, HOG1_AURME) was first released 2025-02-05; the benchmark author's exact source snapshot is unknown, though the sequence has not changed (sequenceVersion 1 throughout).",
    "The reviewer identified the accession via dataset image-path metadata, which was not available to the evaluated model; however, the reasoning argument relies only on the supplied sequence and general kinase biology."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are eliminated outright by sequence length. Option D (position 279) is in the C-terminal tail, inconsistent with a kinase active site. Only option A is biologically defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (C5/H3) explicitly lists ACT_SITE at position 141, 'Proton acceptor', with evidence ECO:0000255|PROSITE-ProRule:PRU00159. Position 141 in the 355-aa sequence corresponds to the aspartate in the HRD catalytic motif (H139-R140-D141), which is the canonical proton-accepting residue in protein kinases. The annotation is computational (PROSITE-ProRule pattern transfer from the kinase family, ECO:0000255), not experimentally validated, but it is the authoritative database assignment for this entry.",
    "evidence_ids": ["C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Three independent reasoning steps distinguish the answer: (1) The protein is 355 amino acids long, so options B (position 2711) and C (position 2153) are physically impossible and are eliminated by simple arithmetic. (2) The sequence contains the hallmark motifs of a eukaryotic protein kinase: a VAIK-type lysine (K49), the HRD catalytic triad (H139-R140-D141), the DFG motif (D159-F160-G161), and the activation-segment APE motif (~position 195). Recognizing these is general kinase biochemistry. (3) In protein kinases the HRD aspartate is the catalytic proton acceptor; it sits at position 141 in this sequence. Position 279 falls in the C-terminal regulatory tail ('FNDADLPVDTWKIMMYSEILDYHNVDAQNGEEVGVPQ'), far from the catalytic cleft, making it implausible as the catalytic center. Thus only option A survives.",
    "missing_item_specific_fact": "None required. The kinase-motif architecture is visible in the supplied sequence, and the two impossible positions are eliminated by length alone.",
    "reason": "A knowledgeable reader can (a) reject B and C because their positions exceed the 355-residue sequence, (b) identify the protein as a kinase from conserved motifs embedded in the sequence, and (c) locate the HRD aspartate (proton acceptor) at position 141 versus a non-catalytic residue at position 279 in the C-terminal tail. No item-specific database lookup is needed."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are eliminated outright by sequence length. Option D (position 279) is in the C-terminal tail, inconsistent with a kinase active site. Only option A is biologically defensible."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational pattern-transfer annotation from the protein-kinase family, not a direct experimental measurement.",
    "The UniProt entry (A0A5B9GBF0, HOG1_AURME) was first released 2025-02-05; the benchmark author's exact source snapshot is unknown, though the sequence has not changed (sequenceVersion 1 throughout).",
    "The reviewer identified the accession via dataset image-path metadata, which was not available to the evaluated model; however, the reasoning argument relies only on the supplied sequence and general kinase biology."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A5B9GBF0` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 29. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A5B9GBF0.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:49.473180+00:00.  

```json
"A0A5B9GBF0"
```

Source SHA-256: `fba079004196dc4aa9a4146777e2ad8ed7d3390b474caa53a6cffcdd32fef7bf`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A5B9GBF0.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:49.473180+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33375973","source":"PubMed"}],"value":"High osmolarity glycerol response protein 1"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"P32485","source":"UniProtKB"}],"value":"2.7.11.24"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33375973","source":"PubMed"}],"value":"Mitogen-activated protein kinase HOG1"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"33375973","source":"PubMed"}],"value":"MAP kinase HOG1"}]}}
```

Source SHA-256: `fba079004196dc4aa9a4146777e2ad8ed7d3390b474caa53a6cffcdd32fef7bf`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A5B9GBF0.json)  
**Locator:** `/features/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:49.473180+00:00.  

```json
{"description":"Proton acceptor","evidences":[{"evidenceCode":"ECO:0000255","id":"PRU00159","source":"PROSITE-ProRule"}],"location":{"end":{"modifier":"EXACT","value":141},"start":{"modifier":"EXACT","value":141}},"type":"Active site"}
```

Source SHA-256: `fba079004196dc4aa9a4146777e2ad8ed7d3390b474caa53a6cffcdd32fef7bf`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A5B9GBF0?format=txt&versions=29)  
**Locator:** `lines 136-138`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 29 / 1.  
**Retrieved:** 2026-11-01T06:27:31.440600+00:00.  

```text
FT   ACT_SITE        141
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
```

Source SHA-256: `b41aad72deba1b2a50b4811f2707c4302afb398ce10bc95f1c81941f78b1051a`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 30. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
